| Literature DB >> 40688 |
L R Derogatis, M Feldstein, G Morrow, A Schmale, M Schmitt, C Gates, B Murawski, J Holland, D Penman, N Melisaratos, A J Enelow, L M Adler.
Abstract
The present study examined the prescription practices concerning psychotropic drugs in 5 major oncology centers over a 6 month period. During the survey period 1579 patients were admitted to the collaborating institutions, and 51% of them were prescribed at least one psychotropic medication. Hypnotics were the most frequently prescribed drugs, accounting for 48% of total prescriptions, followed by anti-psychotics at 26% and anti-anxiety agents at 25%. Anti-depressant drugs accounted for only 1% of psychotropic prescriptions. Analysis of prescription rationales revealed that 44% of the psychotropic prescriptions were written for sleep, while 25% were given for nausea and vomiting; approximately 17% were attributed to psychological distress, and 12% were associated with diagnostic medical procedures. The overall rate of prescription was approximately 2 psychotropic drugs per patient per admission, with only 2% of prescriptions resulting in chart-documented side effects. At the level of individual compounds, 3 distinct drugs accounted for 72% of total prescriptions--flurazepam (33%), prochlorperazine (21%), and diazepam (17%).Entities:
Mesh:
Substances:
Year: 1979 PMID: 40688 DOI: 10.1002/1097-0142(197911)44:5<1919::aid-cncr2820440555>3.0.co;2-t
Source DB: PubMed Journal: Cancer ISSN: 0008-543X Impact factor: 6.860